112 related articles for article (PubMed ID: 7836694)
1. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat.
Jansen-Olesen I; Goadsby PJ; Uddman R; Edvinsson L
J Auton Nerv Syst; 1994 Sep; 49 Suppl():S97-103. PubMed ID: 7836694
[TBL] [Abstract][Full Text] [Related]
2. Helospectin/helodermin-like peptides in guinea pig lung: distribution and dilatory effects.
Cardell LO; Sundler F; Uddman R
Regul Pept; 1993 Jun; 45(3):435-43. PubMed ID: 8351407
[TBL] [Abstract][Full Text] [Related]
3. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat.
Uddman R; Goadsby PJ; Jansen-Olesen I; Edvinsson L
J Cereb Blood Flow Metab; 1999 Jan; 19(1):61-7. PubMed ID: 9886356
[TBL] [Abstract][Full Text] [Related]
4. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow.
Uddman R; Goadsby PJ; Jansen I; Edvinsson L
J Cereb Blood Flow Metab; 1993 Mar; 13(2):291-7. PubMed ID: 8436621
[TBL] [Abstract][Full Text] [Related]
5. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
[TBL] [Abstract][Full Text] [Related]
6. Unlike VIP, the VIP-related peptides PACAP, helodermin and helospectin suppress electrically evoked contractions of rat vas deferens.
Grundemar L; Håkanson R
Regul Pept; 1992 Aug; 40(3):331-7. PubMed ID: 1438978
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP).
Grundemar L; Högestätt ED
Br J Pharmacol; 1990 Mar; 99(3):526-8. PubMed ID: 2331581
[TBL] [Abstract][Full Text] [Related]
9. Distribution of PACAP (pituitary adenylate cyclase-activating polypeptide)-like and helospectin-like peptides in the teleost gut.
Olsson C; Holmgren S
Cell Tissue Res; 1994 Sep; 277(3):539-47. PubMed ID: 7954690
[TBL] [Abstract][Full Text] [Related]
10. Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.
Lerner UH; Lundberg P; Ransjö M; Persson P; Håkanson R
Calcif Tissue Int; 1994 Apr; 54(4):284-9. PubMed ID: 7914821
[TBL] [Abstract][Full Text] [Related]
11. Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system.
Hauser-Kronberger C; Hacker GW; Albegger K; Muss WH; Sundler F; Arimura A; Dietze O
Regul Pept; 1996 Sep; 65(3):203-9. PubMed ID: 8897643
[TBL] [Abstract][Full Text] [Related]
12. Helospectin and pituitary adenylate cyclase activating polypeptide in the human vagina.
Graf AH; Schiechl A; Hacker GW; Hauser-Kronberger C; Steiner H; Arimura A; Sundler F; Staudach A; Dietze O
Regul Pept; 1995 Feb; 55(3):277-86. PubMed ID: 7761627
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides.
Absood A; Chen D; Håkanson R
Regul Pept; 1992 Aug; 40(3):311-22. PubMed ID: 1332141
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.
Fahrenkrug J; Hannibal J; Tams J; Georg B
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381
[TBL] [Abstract][Full Text] [Related]
15. Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea.
Wagner U; Bredenbröker D; Storm B; Tackenberg B; Fehmann HC; von Wichert P
Peptides; 1998; 19(2):241-5. PubMed ID: 9493855
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
[TBL] [Abstract][Full Text] [Related]
17. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs.
Seki Y; Suzuki Y; Baskaya MK; Kano T; Saito K; Takayasu M; Shibuya M; Sugita K
Eur J Pharmacol; 1995 Mar; 275(3):259-66. PubMed ID: 7768293
[TBL] [Abstract][Full Text] [Related]
18. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
19. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation.
Tsueshita T; Onyükusel H; Sethi V; Gandhi S; Rubinstein I
Peptides; 2004 Jan; 25(1):65-9. PubMed ID: 15003357
[TBL] [Abstract][Full Text] [Related]
20. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries.
Dalsgaard T; Hannibal J; Fahrenkrug J; Larsen CR; Ottesen B
Regul Pept; 2003 Feb; 110(3):179-88. PubMed ID: 12573798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
